Pre-Clinical Phases Biomarker Assays

CASPASE3 DEVDR110 ASSAY (25 ASSAYS)

30008-1 1KIT
EUR 244.8
Description: Minimum order quantity: 1 unit of 1KIT

Biomarker Assay Laboratories manufactures the pre-clinical phases biomarker assays reagents distributed by Genprice. The Pre-Clinical Phases Biomarker Assays reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact biomarker assay. Other Pre-Clinical products are available in stock. Specificity: Pre-Clinical Category: Phases Group: Biomarker Assays

PicaGreen-dsDNA-Assay-Kit-*2000-assays*

1-mL
EUR 1316.67
Description: DsDNA,-ssDNA,-RNA-quantitative-detection-kit

OligoGreen-ssDNA-Assay-Kit-*2000-assays*

1-mL
EUR 1316.67
Description: DsDNA,-ssDNA,-RNA-quantitative-detection-kit

soluble collagen assay kit 96-assays

1 plate 96 assays
EUR 400.8

hydroxyproline assay kit 2x 96-assays

2 plates 192 assays
EUR 708

total collagen assay kit 96-assays

1 plate 96 assays
EUR 400.8

total protein assay kit 96-assays

1 plate 96 assays
EUR 345.6

OxiSelect AOPP Assay Kit (200 assays)

200 assays
EUR 762
Description: Advanced Oxidation Protein Products (AOPP) are uremic toxins created during oxidative stress through the reaction of plasma proteins with chlorinated oxidants such as chloramines or hypochlorous acid. AOPP levels are elevated in patients with renal complications, diabetes mellitus, and atherosclerosis, as well as HIV-positive patients. Our OxiSelect AOPP Assay Kit provides a convenient method to assess oxidative stress. The kit includes a Chloramine standard and an AOPP Human Serum Albumin conjugate for use as a positive control.

Biomarker Assays information

Clinical 4-Way Rack Purple PK5

RAC0028 PK5
EUR 123.6

Clinical Waste bags Yellow HD 15x28x39

SAF0172 PK100
EUR 54.18

MYC-D (Clinical Samples) Control Slides

25419-1 1box
EUR 140

Refractometer Clinical DIGIT 012 Hand Held

REF1600 EACH
EUR 162

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), 0.2mg/mL

BNUB2430-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), 0.2mg/mL

BNUB2430-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(YBX1/2430), 1mg/mL

BNUM2430-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), 0.2mg/mL

BNUB2570-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), 0.2mg/mL

BNUB2570-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker)(rYBX1/2430), 1mg/mL

BNUM2570-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), 0.2mg/mL

BNUB2759-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), 0.2mg/mL

BNUB2759-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), 0.2mg/mL

BNUB2760-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), 0.2mg/mL

BNUB2760-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2759), 1mg/mL

BNUM2759-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma)(BARX1/2760), 1mg/mL

BNUM2760-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Clinical Waste Bags Yellow Heavy Duty 90L

BAG1044 PK100
EUR 58.88